8-K: Chegg Faces NYSE Delisting Warning Over Sub-$1 Share Price

Chegg, Inc. received a notice from the NYSE for non-compliance with its minimum share price requirement, triggering a six-month cure period to avoid potential delisting.

Summary

• Chegg, Inc. was notified by the NYSE on December 12, 2025, of non-compliance with Section 802.01C of the NYSE Listed Company Manual.
• The non-compliance is due to the average closing share price of its common stock being less than $1.00 over a consecutive 30 trading-day period as of December 11, 2025.
• The company has a six-month cure period to regain compliance, during which its common stock will continue to be listed and traded on the NYSE.
• To regain compliance, the company must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period by the end of any calendar month within the cure period.
• Chegg intends to notify the NYSE of its plan to regain compliance and will evaluate options, including a potential reverse stock split, subject to board and stockholder approval.
• Failure to regain compliance could lead to suspension and delisting of the company's common stock from the NYSE.

Sentiment

Score: 3

Explanation: The filing indicates a significant negative event (NYSE non-compliance) which could lead to delisting. While there's a cure period, the underlying issue of a sub-$1 stock price reflects poor market sentiment and potential operational challenges. The mention of a reverse stock split also suggests a reactive measure to a declining stock price.

Positives

• The notice has no immediate impact on the listing of the company's common stock, which will continue to be listed and trade on the NYSE during the six-month cure period.
• The company has a clear path and a six-month period to regain compliance.

Negatives

• The company's common stock average closing price fell below $1.00 for 30 consecutive trading days.
• Risk of potential delisting from the NYSE if compliance is not regained within the six-month period.
• Potential need for a reverse stock split, which can sometimes be viewed negatively by investors.

Risks

• Inability to regain compliance with the NYSE minimum share price requirement within the six-month cure period.
• Failure to maintain compliance with other NYSE listing standards.
• Potential delisting of the company's common stock from the NYSE.
• Reactions from employees, vendors, customers, lenders, and investors to the NYSE notice of non-compliance.
• Impact of the company's commencement of a process to explore strategic alternatives and the outcome of such process.
• General risks and uncertainties outlined in the company's Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent SEC filings.

Future Outlook

The company intends to regain compliance with the NYSE minimum share price requirement within the six-month cure period. This may involve monitoring the share price, evaluating various options, and potentially effecting a reverse stock split, subject to necessary approvals. The company also aims to continue complying with other NYSE listing standards.

Management Comments

• We intend to notify the NYSE timely of our intent to regain compliance with the NYSE minimum share price requirement.
• We intend to continually monitor the closing share price of our common stock throughout the cure period and, as appropriate, will evaluate available options to resolve the deficiency and regain compliance with the minimum share price requirement.

Industry Context

This event highlights the challenges faced by some companies in the education technology sector, particularly those undergoing strategic shifts or facing market pressures, which can impact investor confidence and stock valuation. Maintaining listing standards is crucial for market visibility and access to capital.

Stakeholder Impact

• Shareholders: Face potential dilution from a reverse stock split, risk of delisting, and reduced liquidity if delisted.
• Employees: May experience uncertainty regarding the company's future and stability.
• Customers: Could perceive reduced company stability, though direct service impact is not indicated.
• Lenders/Vendors: May reassess credit terms or business relationships due to increased financial risk.

Next Steps

• Notify the NYSE of intent to regain compliance.
• Continuously monitor the closing share price of common stock.
• Evaluate available options to resolve the deficiency and regain compliance, potentially including a reverse stock split.
• Seek approval from the board of directors and stockholders if a reverse stock split is deemed necessary.

Key Dates

Recommendation

The NYSE delisting notice due to a sustained sub-$1 share price is a severe negative indicator. While a cure period exists, the underlying issues causing such a low valuation are significant. A potential reverse stock split, while a mechanism to regain compliance, does not address the fundamental business challenges and often signals further weakness. The risk of delisting, coupled with the negative market sentiment reflected in the share price, suggests a high level of uncertainty and potential for further value erosion. Investors should consider selling to mitigate further losses, as the path to sustainable recovery and regaining investor confidence appears challenging.

Keywords

Chegg, NYSE, Delisting, Share Price, Non-compliance, Reverse Stock Split, CHGG, SEC Filing, 8-K, Stock Market, Corporate Governance